PHARMA-BIO SERV, INC. (PBSV) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
30/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LosePBSV / S&P 11.76% / 15.20% |
LosePBSV / S&P -5.49% / 15.00% |
LosePBSV / S&P -123.53% / 50.40% |
| 2026-Q11/3 |
WinPBSV / S&P -2.62% / -4.33% |
LosePBSV / S&P -8.08% / 11.30% |
LosePBSV / S&P -109.38% / 27.70% |
| 2025-Q40/3 |
LosePBSV / S&P -10.45% / 2.65% |
LosePBSV / S&P -5.34% / 9.00% |
LosePBSV / S&P -106.58% / 13.40% |
| 2025-Q31/3 |
WinPBSV / S&P 31.37% / 8.12% |
LosePBSV / S&P -14.75% / 4.61% |
LosePBSV / S&P PBSV unavailable / 13.45% |
| 2025-Q20/3 |
LosePBSV / S&P 2.00% / 10.94% |
LosePBSV / S&P -25.46% / 4.83% |
LosePBSV / S&P PBSV unavailable / 10.63% |
| 2025-Q11/3 |
WinPBSV / S&P 3.90% / -4.27% |
LosePBSV / S&P -36.50% / 4.98% |
LosePBSV / S&P PBSV unavailable / 10.57% |
| 2024-Q40/3 |
LosePBSV / S&P -15.38% / 2.41% |
LosePBSV / S&P -43.99% / 5.25% |
LosePBSV / S&P PBSV unavailable / 6.15% |
| 2024-Q30/3 |
LosePBSV / S&P 0.00% / 5.89% |
LosePBSV / S&P -40.20% / 5.89% |
LosePBSV / S&P PBSV unavailable / 6.11% |
| 2024-Q20/3 |
LosePBSV / S&P -23.53% / 4.28% |
LosePBSV / S&P -28.99% / 5.38% |
LosePBSV / S&P PBSV unavailable / 5.12% |
| 2024-Q10/3 |
LosePBSV / S&P -12.76% / 10.56% |
LosePBSV / S&P -18.80% / 5.71% |
LosePBSV / S&P PBSV unavailable / 5.59% |
| 2023-Q40/3 |
LosePBSV / S&P 1.94% / 11.69% |
LosePBSV / S&P -12.48% / 6.81% |
LosePBSV / S&P PBSV unavailable / 7.78% |
| 2023-Q31/3 |
WinPBSV / S&P 14.44% / -3.27% |
LosePBSV / S&P -11.50% / 7.52% |
LosePBSV / S&P PBSV unavailable / -5.03% |
| 2023-Q20/3 |
LosePBSV / S&P -4.26% / 8.74% |
LosePBSV / S&P -11.46% / 9.50% |
LosePBSV / S&P PBSV unavailable / -8.57% |
| 2023-Q11/3 |
WinPBSV / S&P 27.29% / 7.50% |
LosePBSV / S&P -9.82% / 10.77% |
LosePBSV / S&P PBSV unavailable / -15.69% |
| 2022-Q40/3 |
LosePBSV / S&P -1.25% / 7.56% |
LosePBSV / S&P -3.56% / 11.88% |
LosePBSV / S&P PBSV unavailable / -17.99% |
| 2022-Q31/3 |
WinPBSV / S&P -1.23% / -4.88% |
LosePBSV / S&P 4.17% / 13.47% |
LosePBSV / S&P PBSV unavailable / -1.41% |
| 2022-Q21/3 |
WinPBSV / S&P -10.00% / -16.10% |
LosePBSV / S&P -1.26% / 13.71% |
LosePBSV / S&P PBSV unavailable / 11.04% |
| 2022-Q10/3 |
LosePBSV / S&P -4.77% / -4.60% |
LosePBSV / S&P -3.70% / 15.97% |
LosePBSV / S&P PBSV unavailable / 42.23% |
| 2021-Q40/3 |
LosePBSV / S&P 10.43% / 11.03% |
LosePBSV / S&P -6.72% / 15.00% |
LosePBSV / S&P PBSV unavailable / 96.40% |
| 2021-Q30/3 |
LosePBSV / S&P -24.06% / 0.58% |
LosePBSV / S&P -8.52% / 10.77% |
LosePBSV / S&P PBSV unavailable / 69.42% |
| 2021-Q20/3 |
LosePBSV / S&P 8.13% / 8.55% |
LosePBSV / S&P 3.90% / 6.58% |
LosePBSV / S&P PBSV unavailable / 51.81% |
| 2021-Q11/3 |
LosePBSV / S&P -10.37% / 6.17% |
WinPBSV / S&P 9.64% / -1.06% |
LosePBSV / S&P PBSV unavailable / 7.39% |
| 2020-Q42/3 |
WinPBSV / S&P 12.40% / 12.15% |
WinPBSV / S&P 10.55% / -3.72% |
LosePBSV / S&P PBSV unavailable / -33.42% |
| 2020-Q32/3 |
WinPBSV / S&P 51.76% / 8.93% |
WinPBSV / S&P 4.94% / -2.04% |
LosePBSV / S&P PBSV unavailable / -27.10% |
| 2020-Q21/3 |
LosePBSV / S&P 3.66% / 20.54% |
WinPBSV / S&P 0.15% / -0.46% |
LosePBSV / S&P PBSV unavailable / -27.11% |
| 2020-Q12/3 |
WinPBSV / S&P -5.75% / -19.60% |
WinPBSV / S&P 4.92% / 3.47% |
LosePBSV / S&P PBSV unavailable / -14.75% |
| 2019-Q41/3 |
LosePBSV / S&P -3.93% / 9.07% |
WinPBSV / S&P 9.61% / 5.36% |
LosePBSV / S&P PBSV unavailable / 2.99% |
| 2019-Q32/3 |
WinPBSV / S&P 5.32% / 1.70% |
WinPBSV / S&P 51.09% / 5.02% |
LosePBSV / S&P PBSV unavailable / 0.21% |
| 2019-Q21/3 |
LosePBSV / S&P -11.32% / 4.30% |
WinPBSV / S&P 56.15% / 6.64% |
LosePBSV / S&P PBSV unavailable / 8.65% |
| 2019-Q11/3 |
LosePBSV / S&P 6.00% / 13.65% |
WinPBSV / S&P 43.61% / 8.12% |
LosePBSV / S&P PBSV unavailable / 14.29% |
| 2018-Q41/3 |
WinPBSV / S&P 17.51% / -13.52% |
LosePBSV / S&P PBSV unavailable / 9.05% |
LosePBSV / S&P PBSV unavailable / 18.23% |
| 2018-Q32/3 |
WinPBSV / S&P 43.75% / 7.71% |
LosePBSV / S&P PBSV unavailable / 10.21% |
WinPBSV / S&P 86.67% / 19.06% |
| 2018-Q22/3 |
WinPBSV / S&P 20.75% / 3.43% |
LosePBSV / S&P PBSV unavailable / 9.03% |
WinPBSV / S&P 155.93% / 14.46% |
| 2018-Q12/3 |
WinPBSV / S&P 1.92% / -0.76% |
LosePBSV / S&P PBSV unavailable / 7.68% |
WinPBSV / S&P 269.77% / 12.46% |
| 2017-Q42/3 |
WinPBSV / S&P 57.58% / 6.64% |
LosePBSV / S&P PBSV unavailable / 7.03% |
WinPBSV / S&P 454.55% / 13.82% |
| 2017-Q30/3 |
LosePBSV / S&P -52.17% / 4.48% |
LosePBSV / S&P PBSV unavailable / 5.68% |
LosePBSV / S&P -281.82% / 17.57% |
| 2017-Q20/3 |
LosePBSV / S&P -1.43% / 3.09% |
LosePBSV / S&P PBSV unavailable / 4.83% |
LosePBSV / S&P -201.72% / 17.74% |
| 2017-Q10/3 |
LosePBSV / S&P -29.29% / 6.07% |
LosePBSV / S&P PBSV unavailable / 3.67% |
LosePBSV / S&P -160.56% / 13.32% |
| 2016-Q41/3 |
WinPBSV / S&P 16.47% / 3.82% |
LosePBSV / S&P PBSV unavailable / 2.09% |
LosePBSV / S&P -116.18% / 7.05% |
| 2016-Q30/3 |
LosePBSV / S&P -8.60% / 3.85% |
LosePBSV / S&P PBSV unavailable / 0.20% |
LosePBSV / S&P -59.26% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PBSV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 3.11% | 20.78% |
| Annualized return | 3.11% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | PBSV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -17.07% | 83.14% |
| Annualized return | -3.67% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | PBSV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 33.47% | 319.30% |
| Annualized return | 2.93% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.